论文部分内容阅读
MicroRNAs have the potential to be used as biomarkers for diagnosis and prognosis of cancer.MicroRNA-16 (miR-16) frequently deleted or downregulated in patients with B cell chronic lymphocytic leukemia and thus can be used as promising biomarkers in B-CLLs diagnosis and prognosis.